Michael J. McGinley, Presi, Biologic. & Pharm at HESKA CORP (HSKA), sold 22,378 shares at $98.53 ($2.2M) on 2017-05-31, disclosed to the SEC on 2017-06-01.
Open-market sale of $2.2M HSKA by Presi, Biologic. & Pharm. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $98.53 | 5,130 | $505K | 22.9% |
| 2 | $98.53 | 5,130 | $505K | 22.9% |
| 3 | $98.53 | 6,059 | $597K | 27.1% |
| 4 | $98.53 | 6,059 | $597K | 27.1% |
| Total | $98.53 avg | 22,378 | $2.2M | 100% |
| Filing → |
| HSKA | SELL | 2016-11-09 | $729K | — | Filing → |
| HSKA | SELL | 2016-05-10 | $219K | — | Filing → |
| HSKA | SELL | 2015-11-25 | $48K | — | Filing → |